Biomerica, Inc.
BMRA
$2.38
-$0.02-0.63%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -66,100.00% | 100.13% | -32.76% | -22.42% | 27.81% |
| Total Depreciation and Amortization | 0.98% | -1.92% | 5.05% | -1.00% | 3.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.01% | 12.66% | 119.44% | -51.35% | 57.45% |
| Change in Net Operating Assets | 122.00% | -188.57% | 1,271.70% | 40.45% | 59.36% |
| Cash from Operations | -269.78% | 59.46% | 36.75% | -32.11% | 41.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 87.88% | -- |
| Cash from Investing | -- | -- | 100.00% | 87.88% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -47.50% | -- | -- | 350.77% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.11% | -375.00% | 87.10% | -158.33% | -- |
| Cash from Financing | -47.61% | 18,500.00% | -100.29% | 356.84% | -- |
| Foreign Exchange rate Adjustments | -150.00% | -75.00% | 900.00% | 75.00% | 33.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.98% | 199.39% | -195.92% | 253.13% | 66.81% |